EVRYSDI (risdiplam) for oral solution

EVRYSDI is a prescription medicine used for the treatment of spinal muscular atrophy (SMA). Brand Name: EVRYSDI (risdiplam) for oral solution Initial U.S. Approval: 2020

EVRYSDI (risdiplam) for oral solution Price In India and Overseas
EVRYSDI (risdiplam) for oral solution

Submit a request to access drug used to treat, diagnose or prevent serious or life-threatening conditions.We’ll get back to you within 1 business days!

For Indian Patient Enquiry under NPP.

For any urgent inquiries or assistance needed, please reach out to our Support Team. Rest assured, we will respond within 24 hours, from Monday to Saturday, during the hours of 9:00 A.M to 18:00 PM.

EVRYSDI (risdiplam) for oral solution

Risdiplam is used to treat spinal muscular atrophy, a rare nerve and muscle disorder that is characterized by loss of lower motor neurons and progressive muscle wasting, often leading to early death.

EVRYSDI is a survival of motor neuron 2 (SMN2) splicing modifier indicated for the treatment of spinal muscular atrophy (SMA) in pediatric and adult patients. Active ingredient: risdiplam
Inactive ingredients: ascorbic acid, disodium edetate dihydrate, isomalt, mannitol, polyethylene glycol 6000, sodium benzoate, strawberry flavor, sucralose, and tartaric acid.

Risdiplam, sold under the brand name Evrysdi, is a medication used to treat spinal muscular atrophy (SMA) and the first oral medication approved to treat this disease. Risdiplam was approved by the US Food and Drug Administration (FDA) in August 2020, for the treatment of adults and children two months of age or older.

Drug (Brand / Generic): EVRYSDI / risdiplam
Current Indications: spinal muscular atrophy (SMA)
Marketed by:: Genentech
Approval Date: 2020

Dosage forms and strengths of EVRYSDI (risdiplam) for oral solution
For Oral Solution: 60 mg of risdiplam as a powder for constitution to provide 0.75 mg/mL solution

For more highlights of prescribing information regarding Indications and usage, dosage and administration, dosage forms and strengths, patient counseling information and medication guide. Click Here

Alleviare Life Sciences

About Us

Alleviare Life Sciences Pvt. Ltd. (India) serves as a facilitator for medical and pharmaceutical products, commencing its operations in 2005. Headquartered in Delhi, India, Alleviare operates nationwide, providing a range of comprehensive services to patients, doctors, hospitals, and government healthcare facilities.

Our specialization lies in facilitating access to medicines, leveraging our expertise in sourcing and providing documentation assistance for programs such as Named Patient Program, Managed Access Program, and Early Access Program. We take pride in ensuring smooth and efficient access to medications for those who require them.

Alleviare India, a certified pharmaceutical facilitator / supplier / importer of specialty medicines or drugs based in India.